why choose us

Clinical Trials Search

Showing 6,470 of 132,656 result(s)
Phase I Study of ANK-101 in Advanced Tumors

Status: Completed

Condition: Advanced Solid Tumor

Interventions: IT administration of ANK-101 once every 3 weeks for up to 12 weeks (4 doses); if there is no disease progression, decrease in clinical performance sta

Date: 2023-11-29

Food as Medicine for Families

Status: NOT_YET_RECRUITING

Condition: Diet, Healthy

Interventions: Medically tailored meals will be provided for the enrolled individual, with additional meals provided as needed for others living the same household

Date: 2023-11-29

The Comparative Effectiveness of Interventions in People With Neck Pain Who Exhibit Directional Preference

Status: NOT_YET_RECRUITING

Condition: Neck Pain

Interventions: MDT management is based on the patient response to repeated end range movements.

Date: 2023-11-29

Novel Multifocal Soft Contact Lens Study

Status: Completed

Condition: Myopia

Interventions: A soft contact lens that will be worn only at the study visit.

Date: 2023-11-29

A Single Group Study to Evaluate the Effects of a Myo-Inositol and D-Chiro Inositol Supplement on Symptoms Associated With Polycystic Ovary Syndrome and Hormone Imbalance

Status: ACTIVE_NOT_RECRUITING

Condition: Polycystic Ovary Syndrome

Interventions: This product contains Myo-Inositol, D-Chiro-Inositol, Folate and Vitamin D.

Date: 2023-11-28

Exploration of Synaptotrophic Effects of Psilocybin in Opioid Use Disorder (OUD)

Status: NOT_YET_RECRUITING

Condition: Opioid Use Disorder

Interventions: Participants will receive a single dose of psilocybin administered in 20 mg or 25 mg doses depending on the participant's weight: 20 mg (among pa

Date: 2023-11-28

Impedance During Cardiac Catheterization to Build a Non-Invasive Cardiac Output Algorithm

Status: Completed

Condition: Congenital Heart Disease

Interventions: Continuous vital sign is collected via a research prototype monitor

Date: 2023-11-28

Low Dose Atropine for Symptomatic Vitreous Floaters

Status: NOT_YET_RECRUITING

Condition: Vitreous Floaters

Interventions: 0.01% atropine ophthalmic drop will be applied daily to the affected eye

Date: 2023-11-28

18F-FLUC-CEST PET;MR in Patients With Brain Mets

Status: Completed

Condition: Brain Metastasis

Interventions: Participants will receive PET radiotracer and MRI

Date: 2023-11-28

Comparing SingLe- Vs Multi-Fraction Spine STereotActic Radiosurgery in Spinal Metastases

Status: NOT_YET_RECRUITING

Condition: Spinal Metastases

Interventions: Treatment Arm 1: Single-fraction spine SRS (22 Gy x 1)

Date: 2023-11-28